Medistim
Medistim ASA is a Norwegian medical technology company engaged in the development, manufacturing, and global commercialization of intraoperative blood flow measurement and ultrasound imaging systems. The company specializes in transit-time flow measurement and high-frequency ultrasound devices used primarily during coronary artery bypass graft surgery and vascular surgical procedures. Its proprietary product lines, including the MiraQ system, enable cardiac surgeons to perform real-time intraoperative quality control and graft patency verification. Principal revenue is derived from direct equipment sales, capital equipment leasing, recurring sales of single-use smart probes, and aftermarket maintenance service contracts across hospital networks globally. Medistim holds a dominant global market position as a standard-of-care provider for intraoperative quality assurance equipment in cardiac procedures. Headquartered in Oslo, Norway, the company's common stock is publicly listed and traded on the Oslo Børs under the ticker MEDI.
17 of the funds FundTelligence covers report a position in Medistim.
- Sector
- Health Care
- Country
- Norway
- Funds holding it
- 17
Funds holding Medistim
- Fondita Nordic Micro Cap — Fondita · 4.09 % (largest positions only, October 2026)
- ODIN Small Cap — ODIN · 4.01 % (full portfolio disclosed, September 2026)
- Danske Invest Norge Vekst — Danske Invest · 3.95 % (full portfolio disclosed, September 2026)
- Schroder ISF Nordic Micro Cap — Schroders · 3.07 % (full portfolio disclosed, June 2026)
- Holberg Norge — Holberg · 3.01 % (full portfolio disclosed, October 2026)
- Schroder ISF Nordic Smaller Companies — Schroders · 2.49 % (full portfolio disclosed, June 2026)
- Handelsbanken Microcap Norden — Handelsbanken · 1.99 % (full portfolio disclosed, October 2026)
- Swedbank Robur Småbolagsfond Norden — Swedbank · 1.85 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 17 funds holding it.